Admixing of mRNA with Pre‐Formed Lipid Nanoparticles Containing a Slightly‐Cationic Ionizable Lipid Allows for Efficient mRNA Transfection In Vitro and In Vivo
Advanced Healthcare Materials · 2025
DOI: 10.1002/adhm.202501788 ↗Kurz gefasst
Fachartikel in der Zeitschrift Advanced Healthcare Materials, 2025. Verfasst von Haixiu Wang und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmaceutics, Ghent University, Ottergemsesteenweg 460, Gent, 9000, Belgium. Hauptthemen laut MEDLINE: Transfection, RNA, Messenger, Nanoparticles, Liposomes. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 48 Literaturangaben. Gefördert von: European Union's Horizon 2020 Research and Innovation Program, Flanders Research Fund, Research Foundation Flanders (FWO).
Abstract (Originalsprache)
Therapeutic mRNA has emerged as a powerful tool in medicine. However, due to its fragility and large size, mRNA requires a carrier for delivery into the cellular cytosol. Lipid nanoparticles (LNPs), produced by rapidly mixing an aqueous mRNA solution with an ethanolic solution containing lipids, are currently considered the most advanced carriers for this purpose. Electrostatic interactions between mRNA and the ionizable cationic lipid, combined with hydrophobic interactions among all lipids, lead to self‐assembly into LNPs that accommodate the mRNA in their core. In this study, whether mixing mRNA with pre‐formed, empty LNPs (eLNPs) in an aqueous medium can be a viable alternative for mRNA expression is investigated. It is confirmed that mRNA can associate with eLNPs via electrostatic interactions, with the effectiveness of this association depending on the surface charge of the eLNPs and the ionizable lipid component. Furthermore, post‐loading mRNA into eLNPs demonstrates mRNA expression levels comparable to conventional LNP(mRNA) formulations, both in vitro and in mice. This method of leveraging eLNPs offers a practical alternative to conventional LNP(mRNA) formulation for the rapid screening of multiple mRNAs. It can also enable straightforward use of LNPs for mRNA transfection by users who do not have the capacity to perform LNP formulation.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Pharmaceutics, Ghent University, Ottergemsesteenweg 460, Gent, 9000, Belgium.
- Laboratory of Gene Therapy, Ghent University, Heidestraat 19, Merelbeke, 9820, Belgium.
- Faculty of Pharmaceutical Science, University of British Columbia, 2405 Wesbrook Mall, Vancouver, British Columbia, V6T 1Z3, Canada.
ORCID-Profile: Bruno G De Geest, Zifu Zhong
Förderung
- European Union's Horizon 2020 Research and Innovation Program
- Flanders Research Fund
- Research Foundation Flanders (FWO)
- European Research Council
Zitieren
APA
Wang, H., Lauwers, H., Gontsarik, M., Chen, Y., Sanders, N. N., Cheng, M. H. Y., De Geest, B. G., & Zhong, Z. (2025). Admixing of mRNA with Pre‐Formed Lipid Nanoparticles Containing a Slightly‐Cationic Ionizable Lipid Allows for Efficient mRNA Transfection In Vitro and In Vivo. Advanced Healthcare Materials. https://doi.org/10.1002/adhm.202501788
Vancouver
Wang H, Lauwers H, Gontsarik M, Chen Y, Sanders NN, Cheng MHY, et al. Admixing of mRNA with Pre‐Formed Lipid Nanoparticles Containing a Slightly‐Cationic Ionizable Lipid Allows for Efficient mRNA Transfection In Vitro and In Vivo. Advanced Healthcare Materials. 2025. doi:10.1002/adhm.202501788
BibTeX
@article{Wang2025,
author = {Wang, Haixiu and Lauwers, Heleen and Gontsarik, Mark and Chen, Yong and Sanders, Niek N and Cheng, Miffy Hok Yan and De Geest, Bruno G and Zhong, Zifu},
title = {Admixing of mRNA with Pre‐Formed Lipid Nanoparticles Containing a Slightly‐Cationic Ionizable Lipid Allows for Efficient mRNA Transfection In Vitro and In Vivo},
journal = {Advanced Healthcare Materials},
year = {2025},
doi = {10.1002/adhm.202501788}
}
EUVIMED